Literature DB >> 25817513

Genetic markers of Restless Legs Syndrome in Parkinson disease.

Ziv Gan-Or1, Roy N Alcalay2, Anat Bar-Shira3, Claire S Leblond1, Ronald B Postuma4, Shay Ben-Shachar3, Cheryl Waters2, Amelie Johnson5, Oren Levy2, Anat Mirelman6, Mali Gana-Weisz3, Nicolas Dupré7, Jacques Montplaisir8, Nir Giladi9, Stanley Fahn2, Lan Xiong10, Patrick A Dion11, Avi Orr-Urtreger12, Guy A Rouleau13.   

Abstract

INTRODUCTION: Several studies proposed that Restless Legs Syndrome (RLS) and Parkinson disease (PD) may be clinically and/or etiologically related. To examine this hypothesis, we aimed to determine whether the known RLS genetic markers may be associated with PD risk, as well as with PD subtype.
METHODS: Two case-control cohorts from Tel-Aviv and New-York, including 1133 PD patients and 867 controls were genotyped for four RLS-related SNPs in the genes MEIS1, BTBD9, PTPRD and MAP2K5/SKOR1. The association between genotype, PD risk and phenotype was tested using multivariate regression models.
RESULTS: None of the tested SNPs was significantly associated with PD risk, neither in any individual cohort nor in the combined analysis after correction for multiple comparisons. The MAP2K5/SKOR1 marker rs12593813 was associated with higher frequency of tremor in the Tel-Aviv cohort (61.0% vs. 46.5%, p = 0.001, dominant model). However, the risk allele for tremor in this gene has been associated with reduced RLS risk. Moreover, this association did not replicate in Tremor-dominant PD patients from New-York.
CONCLUSION: RLS genetic risk markers are not associated with increased PD risk or subtype in the current study. Together with previous genetic, neuropathological and epidemiologic studies, our results further strengthen the notion that RLS and PD are likely to be distinct entities.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Genetics; Parkinson disease; Restless Legs Syndrome

Mesh:

Substances:

Year:  2015        PMID: 25817513      PMCID: PMC4441838          DOI: 10.1016/j.parkreldis.2015.03.010

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  28 in total

1.  Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

Authors:  N Turjanski; A J Lees; D J Brooks
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

2.  The heritability of risk and age at onset of Parkinson's disease after accounting for known genetic risk factors.

Authors:  Taye H Hamza; Haydeh Payami
Journal:  J Hum Genet       Date:  2010-03-05       Impact factor: 3.172

3.  Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology.

Authors:  Sean J Pittock; Timothy Parrett; Charles H Adler; Joseph E Parisi; Dennis W Dickson; J Eric Ahlskog
Journal:  Mov Disord       Date:  2004-06       Impact factor: 10.338

Review 4.  Restless legs syndrome and PD: a review of the evidence for a possible association.

Authors:  Diego Garcia-Borreguero; Per Odin; Carolina Serrano
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

5.  Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.

Authors:  Tasneem Peeraully; Eng-King Tan
Journal:  Transl Neurodegener       Date:  2012-02-27       Impact factor: 8.014

6.  MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome.

Authors:  Angela Roco; Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Carmen Martínez; Martín Zurdo; Laura Turpín-Fenoll; Jorge Millán; Teresa Adeva-Bartolomé; Esther Cubo; Francisco Navacerrada; Ana Rojo-Sebastián; Lluisa Rubio; Marisol Calleja; José Francisco Plaza-Nieto; Belén Pilo-de-la-Fuente; Margarita Arroyo-Solera; Elena García-Martín; José A G Agúndez
Journal:  J Neural Transm (Vienna)       Date:  2012-09-22       Impact factor: 3.575

Review 7.  Restless legs syndrome in Parkinson's disease.

Authors:  Roselyne M Rijsman; Louise F Schoolderman; Rob S Rundervoort; Maartje Louter
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

8.  Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.

Authors:  Roy N Alcalay; Anat Mirelman; Rachel Saunders-Pullman; Ming-X Tang; Helen Mejia Santana; Deborah Raymond; Ernest Roos; Martha Orbe-Reilly; Tanya Gurevich; Anat Bar Shira; Mali Gana Weisz; Kira Yasinovsky; Maayan Zalis; Avner Thaler; Andres Deik; Matthew James Barrett; Jose Cabassa; Mark Groves; Ann L Hunt; Naomi Lubarr; Marta San Luciano; Joan Miravite; Christina Palmese; Rivka Sachdev; Harini Sarva; Lawrence Severt; Vicki Shanker; Matthew Carrington Swan; Jeannie Soto-Valencia; Brooke Johannes; Robert Ortega; Stanley Fahn; Lucien Cote; Cheryl Waters; Pietro Mazzoni; Blair Ford; Elan Louis; Oren Levy; Llency Rosado; Diana Ruiz; Tsvyatko Dorovski; Michael Pauciulo; William Nichols; Avi Orr-Urtreger; Laurie Ozelius; Lorraine Clark; Nir Giladi; Susan Bressman; Karen S Marder
Journal:  Mov Disord       Date:  2013-10-15       Impact factor: 10.338

9.  Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1.

Authors:  Juliane Winkelmann; Darina Czamara; Barbara Schormair; Franziska Knauf; Eva C Schulte; Claudia Trenkwalder; Yves Dauvilliers; Olli Polo; Birgit Högl; Klaus Berger; Andrea Fuhs; Nadine Gross; Karin Stiasny-Kolster; Wolfgang Oertel; Cornelius G Bachmann; Walter Paulus; Lan Xiong; Jacques Montplaisir; Guy A Rouleau; Ingo Fietze; Jana Vávrová; David Kemlink; Karel Sonka; Sona Nevsimalova; Siong-Chi Lin; Zbigniew Wszolek; Carles Vilariño-Güell; Matthew J Farrer; Viola Gschliesser; Birgit Frauscher; Tina Falkenstetter; Werner Poewe; Richard P Allen; Christopher J Earley; William G Ondo; Wei-Dong Le; Derek Spieler; Maria Kaffe; Alexander Zimprich; Johannes Kettunen; Markus Perola; Kaisa Silander; Isabelle Cournu-Rebeix; Marcella Francavilla; Claire Fontenille; Bertrand Fontaine; Pavel Vodicka; Holger Prokisch; Peter Lichtner; Paul Peppard; Juliette Faraco; Emmanuel Mignot; Christian Gieger; Thomas Illig; H-Erich Wichmann; Bertram Müller-Myhsok; Thomas Meitinger
Journal:  PLoS Genet       Date:  2011-07-14       Impact factor: 5.917

10.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors:  Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal:  Nat Genet       Date:  2014-07-27       Impact factor: 38.330

View more
  5 in total

1.  TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson's Disease with Opposite Effects.

Authors:  Sadaf Mohtashami; Qin He; Jennifer A Ruskey; Sirui Zhou; Patrick A Dion; Richard P Allen; Christopher J Earley; Edward A Fon; Lan Xiong; Nicolas Dupre; Yves Dauvilliers; Guy A Rouleau; Ziv Gan-Or
Journal:  J Mol Neurosci       Date:  2018-02-05       Impact factor: 3.444

Review 2.  Therapies for Restless Legs in Parkinson's Disease.

Authors:  Valérie Cochen De Cock
Journal:  Curr Treat Options Neurol       Date:  2019-11-09       Impact factor: 3.598

3.  Restless Legs Symptoms and Periodic Leg Movements in Sleep Among Patients with Parkinson's Disease.

Authors:  Donald L Bliwise; Elias G Karroum; Sophia A Greer; Stewart A Factor; Lynn Marie Trotti
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  PTPRD: neurobiology, genetics, and initial pharmacology of a pleiotropic contributor to brain phenotypes.

Authors:  George R Uhl; Maria J Martinez
Journal:  Ann N Y Acad Sci       Date:  2019-01-15       Impact factor: 5.691

5.  Lack of Causal Effects or Genetic Correlation between Restless Legs Syndrome and Parkinson's Disease.

Authors:  Mehrdad A Estiar; Konstantin Senkevich; Eric Yu; Parizad Varghaei; Lynne Krohn; Sara Bandres-Ciga; Alastair J Noyce; Guy A Rouleau; Ziv Gan-Or
Journal:  Mov Disord       Date:  2021-05-11       Impact factor: 9.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.